IMGT Co.,Ltd. (XKON:456570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,090
-30 (-0.23%)
At close: Dec 4, 2025
10.00%
Market Cap 68.39B
Revenue (ttm) 102.33M
Net Income (ttm) 731.32M
Shares Out 5.13M
EPS (ttm) 812.00
PE Ratio 16.43
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,392
Average Volume 2,602
Open 13,390
Previous Close 13,120
Day's Range 12,750 - 13,390
52-Week Range 6,970 - 14,480
Beta 0.94
RSI 68.17
Earnings Date n/a

About IMGT Co.,Ltd.

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems. It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation t... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 456570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.